Watchlist Price Alert

Kyverna Therapeutics Inc. (KYTX)

NASDAQ: KYTX · Real-Time Price · USD

2.96

-0.19 (-6.03%)

At close: Jun 17, 2025, 3:59 PM

2.96

0.00%

After-hours: Jun 17, 2025, 04:04 PM EDT

Kyverna Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-127.48M	-60.37M	-28.89M	-26.35M
Depreciation & Amortization	2.13M	1.71M	1.05M	586K
Stock-Based Compensation	8.36M	2.22M	929K	7.25M
Other Working Capital	7.12M	-659K	-7.03M	-4.5M
Other Non-Cash Items	-5.12M	605K	1.41M	850K
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	7.86M	3.42M	-10.33M	-4.49M
Operating Cash Flow	-114.25M	-52.41M	-36.11M	-22.16M
Capital Expenditures	-2.21M	-621K	-768K	-1.29M
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	-490M	-54.85M	-56.49M	n/a
Sales Maturities Of Investments	323.64M	46.68M	43.17M	n/a
Other Investing Acitivies	7.66M	n/a	-13.33M	n/a
Investing Cash Flow	-160.9M	-8.79M	-14.1M	-1.29M
Debt Repayment	-956K	-781K	-249K	-41K
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	-3.1M	-1M	175K	30K
Financial Cash Flow	337.11M	58.12M	11.88M	72.52M
Net Cash Flow	61.96M	-3.08M	-38.33M	49.08M
Free Cash Flow	-116.45M	-53.03M	-36.88M	-23.44M